标题
UCHL1 promotes cancer stemness in triple-negative breast cancer
作者
关键词
-
出版物
PATHOLOGY RESEARCH AND PRACTICE
Volume 240, Issue -, Pages 154235
出版商
Elsevier BV
发表日期
2022-11-22
DOI
10.1016/j.prp.2022.154235
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- UCHL1, a Deubiquitinating Enzyme, Regulates Lung Endothelial Cell Permeability In Vitro and In Vivo
- (2021) Sumegha Mitra et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
- (2021) Milon Mondal et al. BRITISH JOURNAL OF CANCER
- Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
- (2020) Andriy Marusyk et al. CANCER CELL
- Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
- (2020) Peter Savas et al. CANCER CELL
- Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
- (2020) Nicole Mavingire et al. CANCER LETTERS
- State of art of advanced triple negative breast cancer
- (2019) Parham Khosravi‐Shahi et al. Breast Journal
- Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Tomas G. Lyons CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis
- (2019) Sijia Liu et al. CLINICAL CANCER RESEARCH
- Towards personalized treatment for early stage HER2-positive breast cancer
- (2019) Kristina Goutsouliak et al. Nature Reviews Clinical Oncology
- Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
- (2018) Christopher J O'Conor et al. Biomarkers in Medicine
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma
- (2017) Patricia C. Sanchez-Diaz et al. PLoS One
- Cancer stem cells and their implication in breast cancer
- (2014) E. Carrasco et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients
- (2013) Christine Schröder et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance
- (2013) Chengmeng Jin et al. Journal of Cancer
- UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity
- (2012) JIALING ZHONG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
- (2011) Ramesh Ummanni et al. Molecular Cancer
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
- (2010) H. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started